secwatch.observer — SEC 8-K summary
======================================

Issuer:     SCYNEXIS INC (SCYX)
CIK:        0001178253
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001193125-26-134476
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SCYNEXIS discusses asset acquisition in corporate update call
-------------------------------------------------------------

- Conference call held on March 31, 2026 covering an asset acquisition transaction.
- Slide presentation filed as Exhibit 99.1; no financial terms disclosed in this 8-K.
- Company's deck highlights focus on severe rare disease solutions.
- No specific revenue, earnings, or closing timeline provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178253/000119312526134476/0001193125-26-134476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178253/000119312526134476/d114312d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-134476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer